Elastin Receptor and Cell-Matrix Interactions in Heart Transplant-Associated Arteriosclerosis

Archivum Immunologiae et Therapiae Experimentalis

Volumn 45, Issue 1, 1997, Pages 15-29

  Hinek, Aleksander ^a,b  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Arteriosclerosis; Elastin; Extracellular matrix; Fibronectin; Growth factors; Interleukins; MHC

Indexed keywords

CELL SURFACE RECEPTOR; ELASTIN; ELASTIN BINDING PROTEINS; ELASTIN-BINDING PROTEINS;

ANIMAL; ARTERIOSCLEROSIS; CELL COMMUNICATION; EXTRACELLULAR MATRIX; HEART TRANSPLANTATION; HUMAN; IMMUNOLOGY; METABOLISM; REVIEW;

ANIMALS; ARTERIOSCLEROSIS; CELL COMMUNICATION; ELASTIN; EXTRACELLULAR MATRIX; HEART TRANSPLANTATION; HUMANS; RECEPTORS, CELL SURFACE;

EID: 0030623989     PISSN: 0004069X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (114)

1. AKIYAMA S. K., NAGATA K. and YAMADA K. M. (1990): Cell surface receptor for extracellular matrix components. Biochim. Biophys. Acta, 1031, 91-110.
2. ALBELDA S. and BUCK C. (1990): Integrins and other cell adhesion molecules. FASEB J., 4, 2868-2880.
3. ALBELDA S., SMITH C. W. and WARD P. A. (1994): Adhesion molecules and inflammatory injury. FASEB J., 8, 504-512.
4. ALLEN M., MCDONALD T., CARLOS T., HIMES T., FISHBEIN D., AZIZ S. and GORDON D. (1992): Endothelial adhesion molecules in heart transplantation. J. Heart Lung Transplant., 11, 8-13.
5. BALKWILL F. and BURKE F. (1989): The cytokine network. Immunol. Today, 10, 299-304.
6. BENITZ W. E. and BERNFIELD M. (1990): Endothelial cell proteoglycans. Possible mediators of vascular response to injury. Am. J. Respir. Cell. Mol. Biol., 2, 407-408.
7. BERENSON G. S., RADHAKRISHNAMURTHY B., SRINIVASAN S. R., VIJAYAGOPAL P. and DALFERES E. J. (1988): Arterial wall injury and proteoglycan changes in atherosclerosis. Arch. Pathol. Lab. Med., 112, 1002-1010.
8. BERMAN J. W. and CALDBRON T. M. (1992): The role of endothelial cell adhesion molecules in the development of atherosclerosis. Cardiovasc. Pathol., 1, 17-28.
9. BEVILACQUA M. and NELSON R. (1993): Selectins. J. Clin. Invest., 91, 379-387.
10. BILLINGHAM M. (1992): Histopathology of graft coronary disease. J. Heart Lung Transplant., 11, 38-44.
11. BILLINGHAM M., STARNES V. and CLAYBERGER C. (1992): Cytokine gene expression in rejecting cardiac allografts. Transplantation, 54, 326-332.
12. BINAH O. (1994): Immune effector mechanisms in heart transplant rejection. Cardiovasc. Res., 28, 1748-1757.
13. BOBIK A. and CAMPBELL J. (1993): Vascular derived growth factors. Cell biology, pathophysiology, and pharmacology. Pharmacol. Rev., 45, 1-42.
14. BOUDREAU N. and RABINOVITCH M. (1991): Developmentally regulated changes in extracellular matrix in endothelial and smooth muscle cells in the ductus arteriosus may be related to intimal proliferation. Lab. Invest., 64, 187-199.
15. BOUDREAU N., TURLEY E. and RABINOVITCH M. (1991): Fibronectin, hyaluronan and a hyaluronan binding protein contribute to increased migration of ductus arteriosus smooth muscle cell. Dev. Biol., 143, 235-247.
16. BRISCOE D., SCHOEN F., RICE G., BEVILACQUA M., GANZ P. and POBER J. (1991): Induced expression of endothelial-leukocyte adhesion molecules in human cardiac allografts. Transplantation, 51, 537-539.
17. BROWN P. L., MECHAM L., TISDALE C. and MECHAM R. P. (1992): The cysteine residues in the carboxy terminal domain of tropoelastin form an intrachain disulfide bond that stabilizes a loop structure and positively charged pocket. Biochem. Biophys. Res. Commun., 189, 549-555.
18. CARLOS T. M. and HARLAN J. M. (1994): Leukocyte-endothelial adhesion molecules. Blood, 84, 2068-2101.
19. CASTRONOVO V. (1993): Laminin receptors and laminin-binding proteins during tumor invasion and metastasis. Invas. Metast., 13, 1-30.
20. CHIARINI A., FIORILLI A., DIFRANCESCO L., VENERANDO B. and TETTAMANTI G (1993): Human erythrocyte sialidase is linked to the plasma membrane by a glycosylphosphatidylinositol anchor and partly located on the outer surface. Glycoconj. J., 10, 64-71.
21. CLAUSELL N., MOLOSSI S. and RABINOVITCH M. (1993): Increased interleukin-1β and fibronectin expression are early features of the development of the post-cardiac transplant coronary arteriopathy in piglets. Am. J. Pathol., 142, 1772-1786.
22. CLAUSELL N., MOLOSSI S. and RABINOVITCH M. (1993): Tumor necrosis factor-alpha induction of smooth muscle cell fibronectin synthesis via interleukin-1β is associated with the development of graft atherosclerosis. Circulation, 88, 1419-1422.
23. CLAUSELL N., MOLOSSI S., SETT S. and RABINOVITCH M. (1994): In vivo blockade of tumor necrosis factor-α in cholesterol-fed rabbits following cardiac transplant inhibits acute coronary artery neointimal formation. Circulation, 89, 2768-2779.
24. CLAUSELL N. and RABINOVITCH M. (1993): Upregulation of fibronectin synthesis by interleukin-1β in coronary artery smooth muscle cells is associated with the development of the post-cardiac transplant arteriopathy in piglets. J. Clin. Invest., 92, 1850-1858.
25. COWAN B., BARON O., CRACK J., COULBER C., WILSON G. J. and RABINOVITCH M. (1996); Elafin, a serine elastase inhibitor, atenuates post-cardiac transplant coronary artery arteriopathy and reduces myocardial necrosis in rabbits after heterotopic cardiac transplantation. J. Clin. Invest., 97, 1-17.
26. CRISP S., DUNN M., ROSE M., BARBIR M. and YACOUB M. (1994): Anti-endothelial antibodies after heart transplantation: The accelerating factor in transplant-associated coronary artery disease. J. Heart Lung Transplant., 13, 81-92.
27. CYBULSKY M. and GIMBRONE M. Jr. (1991): Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. Science, 251, 788-791.
28. DEAN D. C. (1989): Expression of the fibronectin gene. Am. J. Respir. Cell. Mol. Biol., 1, 5-10.
29. DINARELLO C. (1991): Interleukin-1 and interleukin-1 antagonism. Blood, 8, 1627-1652.
30. DUSTIN M. L. and SPRINGER T. A. (1991): Role of lymphocyte adhesion receptors in transient interactions and cell locomotion. Annu. Rev. Immunol., 9, 27-66.
31. EVERETT J., HERSHBERGER R., NORMAN D., CHOU S., RATKOVEC R., COBANOGLU A., OTT G. and HOSENPUD J. (1992): Prolonged cytomegalovirus infection with viremia is associated with development of cardiac allograft vasculopathy. J. Heart Lung Transplant., 11, 133-137.
32. FAURY G., RISTORI M. T., VERDETTI J., JACOB M. P. and ROBERT L. (1995): Effect of elastin peptides on vascular tone. J. Vase. Res., 32, 112-119.
33. GALJAART N. J., GILLEMANS N., HARRIS A., VAN DER HORST G. T. J., VERHEIJEN F. W., GALJAART H. and D'AZZO A. (1988): Expression of cDNA encoding the human "protective protein" associated with lysosomal β-galactosidase and neuraminidase. Homology to yeast proteases. Cell, 54, 755-764.
34. GALJAART N. J., MORREAU H., WILLEMSEN R., GILLEMANS N., BOUTEN E. and D'AZZO A. (1991): Human lysosomal protective protein has cathepsin A-like activity distinct from its protective function. J. Biol. Chem., 266, 14754-14762.
35. GERRITSEN M. E. and BLOOR M. C. (1993): Endothelial cell gene expresion in response to injury. FASEB J., 7, 523-532.
36. GIBSON M. A., KUMARATILAKE J. S. and CLEARY E. G. (1989): The protein complex of the 12-nanometer microfibrils of elastic and non-elastic tissue. J. Biol. Chem., 264, 4560-4598.
37. GLUKHOVA M., FRID M., SHEKHONIN B., VASILEVSKAYA T., GRUNWALS J., SAGINATI M. and KOTELIANSKY V. (1989): Expression of extra domain of fibronectin sequence in vascular smooth muscle cells is phenotype dependent. J. Cell Biol., 109, 357-366.
38. GORDON D. (1992): Growth factors and cell proliferation in human transplant arteriosclerosis, J. Heart Lung Transplant., 11, 7-9.
39. GOSPODAROVICZ D. and TAUBER J. P. (1980): Growth factors and extracellular matrix. Endocr. Rev., 1, 210-227.
40. GUAN J. L. and HYNES R. O. (1990): Lymphoid cells recognize an alternatively spliced segment of fibronectin via the integrin receptor α4 β1. Cell, 60, 53-61.
41. HAMMOND E., YOWELL R., PRICE G., MENLOVE R., OLSEN S., O'CONNELL J., BRISTOW M., DOTY D., MILLAR R., KARWANDE S., JONES K., GAY W. and RENLUND D. (1992): Vascular rejection and its relationship to allograft coronary artery disease. J. Heart Lung Transplant., 11, 111-119.
42. HELDIN U., BOTTGER B. A., LUTHMAN J., JOHANSSONS S. and THYBERG J. (1989): A substrate of the cell-attachment sequence of fibronectin (Arg-Gly-Asp-Ser) is sufficient to promote transition of arterial smooth muscle cells from a contractile to a synthetic phenotype. Dev. Biol., 133, 489-501.
43. HERSHKOVITZ R., MIRON S., COHEN I., MILLER A. and LIDER O. (1992): T lymphocyte adhesion to the fibronectin and laminin components of the extracellular matrix is regulated by the CD4 molecule. Eur. J. Immunol., 22, 7-13.
44. HINEK A. (1994): Nature and multiple functions of the 67 kD elastin/laminin binding protein. Cell Adh. Commun., 2, 185-193.
45. HINEK A. (1995): The spliced variant of β-galactosidase serves as a reusable protective chaperone for tropoelastin. In ROBERT L.: The molecular biology and pathology of elastin tissues. CIBA Foundation Symposium. John Wiley and Sons, Chichester, England, 192, 185-196.
46. HINEK A., BOYLE J. and RABINOVITCH M. (1992): Vascular smooth muscle cell detachment from elastin and migration through elastic laminae is promoted by chondroitin sulfate-induced shedding" of the 67 kD cell surface elastin binding protein. Exp. Cell Res., 203, 344-353.
47. HINEK A., KAWIAK J., CZARNOWSKA E. and BARCEW B. (1984): Effect of agarose and dexamethasone on the nature and production of extracellular matrix components by elastic cartilage chondrocytes. Acta Biol. Hung. Acad. Sci., 35, 245-258.
48. HINEK A., KEELEY F, and CALLAHAN J. W. (1995): Recycling of the 67 kD reusable shuttle protein for tropoelastin is imperative for proper deposition of insoluble elastin by vascular smooth muscle cells. Exp. Cell Res., 220, 1-13.
49. HINEK A., MECHAM R. P., KEELEY F. W. and RABINOVITCH M. (1991): Impaired elastin fiber assembly related to reduced 67 kD elastin binding protein in fetal lamb ductus arteriosus and in cultured aortic smooth muscle cells treated with chondroitin sulfate. J. Clin. Invest., 88, 2083-2094.
50. HINEK A., MOLOSSI S. and RABINOVITCH M. (1996): Exploration of the molecular mechanisms leading to upregulation of fibronectin production by the arterial smooth muscle cells. Exp. Cell Res., 225, 111-120.
51. HINEK A. and RABINOVITCH M. (1993): Ductus arteriosus smooth muscle cells produce a 52 kD tropoelastin associated with impaired assembly of elastic laminae. J. Biol. Chem., 268, 1405-1413.
52. HINEK A. and RABINOVITCH M. (1994): 67 kD elastin binding protein is a protective "companion" of extracellular insoluble elastin and intracellular tropoelastin. J. Cell Biol., 126, 563-574.
53. HINEK A., RABINOVITCH M., KEELEY F. W. and CALLAHAN J. W. (1993): The 67 kD elastin/laminin-binding protein is related to an alternatively spliced β-galactosidase. J. Clin. Invest., 91, 1198-1205.
54. HINEK A., WRENN D. S., MECHAM R. P. and BARONDES S. H. (1988): The elastin receptor. A galactoside-binding protein. Science, 239, 1539-1541.
55. HORNEBECK W., BRECHEMIER D., SOLEILHAC J. M., BOURDILLON M. C. and ROBERT L. (1985): Studies on rat aorta smooth muscle cells elastase activity. Extracellular matrix: structure and function. Alan R. Liss, Inc., New York, 269-282.
56. HYNES R. O. (1992): Integrins: versatility, modulation, and signalling in cell adhesion. Cell, 69, 11-25.
57. IP V., FUSTER V., BADIMON L., BADIMON J., TAUBMAN M. and CHESEBRO J. (1990): Syndromes of accelerated atherosclerosis. Role of vascular injury and smooth muscle cell proliferation. J. Am. Coll. Cardiol., 15, 1667-1687.
58. ITOH K., KASE R., SHIMMOTO M., SATAKE A., SAKURABA H. and SUZUKI Y. (1995): Protective protein as an endogenous endothelin degradation enzyme in human tissues. J. Biol. Chem., 270, 515-518.
59. JOHNSON M. (1992): Transplant coronary disease. Nonimmunologic risk factors. J. Heart Transplant., 11, 124-132.
60. JULIANO R. L. and HASKILL S. (1993): Signal transduction from the extracellular matrix. J. Cell Biol., 120, 577-585.
61. KEELEY F. and JOIINSON D. J. (1985): The effect of induced atherosclerosis on synthesis of elastin in chick aortic tissue. Atherosclerosis, 54, 311-319.
62. KELSO A. (1989): Cytokines: structure, function, and synthesis. Curr. Opin. Immunol., 2, 215-225.
63. LE J. and VILCEK J. (1987): Tumor necrosis factor and interleukin-1. Cytokines with multiple overlapping biological activities. Lab. Invest., 56, 234-248.
64. LIBBY P. and HANSSON G. (1991): Involvement of the immune system in human atherogenesis: current knowledge and unanswered questions. Lab. Invest., 64, 5-15.
65. LIBBY P., SALOMON R., PAYNE D., SCHOEN F. and POBER J. (1989): Functions of vascular wall cells related to development of transplantation-associated coronary arteriosclerosis. Transplant. Proc., 21, 3677-3684.
66. LIN C. Q. and BISSELL M. (1993): Multi-faceted regulation of cell differentiation by extracellular matrix. FASEB J., 7, 737-743.
67. LIOTTA L. A., RAO C. N. and WEWER U. M. (1986): Biochemical interactions of tumor cells with the basement membrane. Annu. Rev. Biochem., 55, 300-311.
68. LIPTAY M., PARKS W., MECHAM R. P., ROBY J., KAISER L., COOPER J. and BOTNEY M. (1993): Neointimal macrophages colocalize with extracellular matrix gene expression in human atherosclerotic pulmonary arteries. J. Clin. Invest., 91, 588-594.
69. LOPPNOW H. and LIBBY P. (1992): Functional significance of human vascular smooth muscle cell-derived interleukin 1 in paracrine and autocrine regulation pathways. Exp. Cell Res., 198, 283-290.
70. MAORI J. A. and BASSON M. D, (1992): Extracellular matrix-cell interactions; dynamic modulators of cell, tissue and organism structure and function. Lab. Invest., 66, 519-521.
71. MARÍN C. and MOSQUERA J. (1995): Neuraminidase promotes neutrophil, lymphocyte and macrophage infiltration in the normal rat kidney. Kidney Int., 47, 88-95.
72. MASSIA S. and HUBBELL J. (1992): Vascular endothelial cell adhesion and spreading promoted by the peptide REDV of the IIICS region of plasma fibronectin is mediated by integrin α4 β1. J. Biol. Chem. 267, 14019-14026.
73. MECHAM R. P. (1991): Receptors for laminin on mammalian cells. FASEB J., 5, 2538-2546.
74. MECHAM R. P. and HAUSER J. (1991): The elastin fiber in cell biology of extracellular matrix. In HAY E. D.: Cell biology of extracellular matrix. Second edition, Plenum Press, New York, 79-109.
75. MECHAM R. P., HINEK A., ENTWISTLE R., WRENN D. S., GRIFFIN G. and SENIOR R. M. (1989): Elastin binds to a multifunctional 67-kilodalton peripheral membrane protein. Biochemistry, 28, 3716-3722.
76. MECHAM R. P., HINEK A., GRIFFIN G., SENIOR R. M. and LIOTTA L. R. (1989): 67 kD elastin binding protein is homologous to the tumor cell 67 kD laminin receptor. J. Biol. Chem. 264, 16652-16657.
77. MECHAM R. P., WHITEHOUSE L., HAY M., HINEK A. and SHEETZ M. P. (1991): Visualization of elastin/laminin receptor complexes with gold-tagged ligands. Modulation by carbohydrate and cytoskeleton attachment. J. Cell Biol., 113, 187-194.
78. MILLER L. (1991): Long-term complications of cardiac transplantation. Prog. Cardiovasc. Dis., 33, 279-282.
79. MOLOSSI S., CLAUSELL N. and RABINOVITCH M. (1993): Coronary artery endothelial interleukin-1β mediates enhanced fibronectin production related to post-cardiac transplant arteriopathy in piglets. Circulation, 88, 248-256.
80. MOLOSSI S., CLAUSELL N. and RABINOVITCH M. (1995): Reciprocal induction of tumor necrosis factor-α and interleukin-1β activity mediates fibronectin synthesis in coronary artery smooth muscle cells. J. Cell Physiol., 163, 19-29.
81. MOLOSSI S., ELICES M., ARHENIUS T., DIAZ R., COULBER C. and RABINOVITCH M. (1995): Blocade of very late antigen-4 integrin binding fibronectin with connecting segment-1 peptide reduces a accelerated coronary arteriopathy in rabbit cardiac allografts. J. Clin. Invest., 95, 2601-2610.
82. MOLOSSI S., ELICES M., ARHENIUS T. and RABINOVITCH M. (1995): Lymphocyte transendothelial migration toward smooth muscle in interleukin-1β stimulated co-cultures id related to fibronectin interactions with α4 β1 and α5 β1 integrins. J. Cell Physiol., 163, 1-26.
83. MOLOSSI S. and RABINOVITCH M. (1995): VLA-4 and lymphocyte trafficking in immuneinflammatory states: novel therapeutic approaches in allograft artegriopathy. Springer Semin. Immunopathol., 16, 443-465.
84. MORREAU H., GALJAART N. J., GILLEMANS N., WILLEMSEN R., VAN DER HORST G. T. J. and D'AZZO A. (1989): Alternative splicing of β-galactosidase mRNA generates the classic lysosomal enzyme and a β-galactosidase-related protein. J. Biol. Chem., 264, 20655-20663.
85. MORREAU H., GALJAART N. J., WILLEMSEN R., GILLEMANS N., ZHU X. Y. and D'AZZO A. (1992): Human lysosomal protective protein. Glycosylation, intracellular transport, and association with β-galactosidase in the endoplasmic reticulum. J. Biol. Chem., 267, 17949-17956.
86. MOYER C., SAJUTHI D., TULLI H. and WILLIAMS J. (1991): Synthesis of IL-1 alpha and IL-1 beta by arterial cells in atherosclerosis. Am. J. Pathol., 138, 951-960.
87. MUNRO J. M. and COTRAN R. S. (1988): The pathogenesis of atherosclerosis. Atherogenesis and inflammation. Lab. Invest., 58, 249-261.
88. NAKAI A., SATOH M., HIRAYOSHI K. and (1992): Involvement of the stress protein HS47 in procollagen processing in endoplasmic reticulum. J. Cell Biol., 117, 903-914.
89. NILSSON J. (1993): Cytokines and smooth muscle cells in atherosclerosis. Cardiovasc. Res., 27, 1184-1190.
90. OHO S. and RABINOVITCH M. (1994): Post-cardiac transplant arteriopathy in piglets is associated with fragmentation of elastin and increased activity of a serine elastase. Am. J. Pathol., 145, 202-210.
91. POTIER M., MICHAULD L., TRANCHEMONTANAGNE J. and THAUVETTE L. (1990): Structure of the lysosomal neuraminidase-β-galactosidase-carboxypeptidase multienzymatic complex. Biochem. J., 267, 197-202.
92. RABINOVITCH M. (1994): Elastase and cell extracellular matrix interactions in the pathogenesis of intimai proliferation. In WOODFORD E. P., DAVIGNON J. and SNIDERMAN A.: Atherosclerosis. Elsevier, New York, 338-349.
93. RAINES E. and Ross R. (1993): Smooth muscle cells and the pathogenesis of the lesions of atherosclerosis. Br. Heart J., 69 (suppl.), 30-37.
94. ROSENBLOOM J., ABRAMS W. R. and MECHAM R. P. (1993): Extracellular matrix. The elastic fiber. FASEB J., 7, 1208-1218.
95. Ross R. (1993): Atherosclerosis. A defense mechanism gone awry. Am. J. Pathol., 143, 987-1002.
96. Ross R. (1993): The pathogenesis of atherosclerosis. A perspective for the 1990s. Nature, 362, 801-809.
97. RUBANYI G. M. and POLOKOFF M. A. (1994): Endothelins. Molecular biology, biochemistry, pharmacology, physiology and pathophysiology. Pharmacol. Rev., 46, 325-415.
98. RUSSELL M., FUJITA M., MASEK M., ROWAN R. and BILLINGHAM M. (1993): Cardiac graft vascular disease. Nonselective involvement of large and small vessels. Transplantation, 56, 762-764.
99. SAKAI L. Y., KEENE D. R. and ENGVALL E. (1986): Fibrillin, a new 350 kD glycoprotein, is a component of extracellular microfibrils. J. Cell Biol., 103, 2499-2507.
100. SALOMON R., HUGHES C., SCHOEN F., PAYNE D., POBER J. and LIBBY P. (1991): Human coronary transplantation-associated arteriosclerosis. Am. J. Pathol., 138, 791-798.
101. SCHUBERT D. (1992): Collaborative interactions between growth factors and the extracellular matrix. Trends Cell Bio., 2, 63-66.
102. SENIOR R. M., GRIFFIN G., MECHAM R. P., WRENN D. S., PRASAD K. U. and URRY D. W. (1984): Val-Gly-Val-Ala-Pro-Gly, a repeating peptide in elastin is chemotactic for fibroblasts and monocytes. J. Cell Biol., 99, 870 -874.
103. SENIOR R. M., HINEK A., GRIFFIN G., CRAUCH E. and MECHAM R. P. (1989): Neutrophils are chemotactic to type IV collagen and its 7S domain and contain 67 kDa type IV collagen binding protein with galactolectin properties. Am. J. Respir. Cell. Molec. Biol., 1, 479-487.
104. SENIOR R. M., ROMAN J., HINEK A. and MECHAM R. P. (1989): Extracellular matrix components as mediators of inflammation. In HANSON P. M. and MURPHY P. C.: Handbook of inflammation. Mediators of inflammatory process. Elsevier Science Publ., New York, 6, 339-359.
105. SHEKHONIN B. V., DOMOGATSKY S. P., IDELSON G. L., KOTELIANSKY V. E. and RUKOSUEV V. S. (1987): Relative distribution of fibronectin and type I, III, IV, V collagens in normal and atherosclerotic intima of human arteries. Atherosclerosis, 67, 9-16.
106. SIMIONESCU M. and SIMIONESCU N. (1993): Proatherosclerotic events: pathobiochemical changes occurring in the arterial wall before monocyte migration. FASEB J., 7, 1359-1366.
107. SPRINGER T. (1990): Adhesion receptors of the immune system. Nature, 346, 425-434.
108. THIERY J. P. and BOYER B. (1992): The junction between cytokines and cell adhesion. Curr. Opin. Cell Biol., 4, 782-792.
109. WAGNER W. D. (1985): Proteoglycan structure and function as related to atherosclerosis. Ann. N. Y. Acad. Sci, 3, 2-68.
110. WIGHT T. (1989): Cell biology of arterial proteoglycans. Atherosclerosis, 9, 1-20.
111. WIGHT T. N., KINSELA M. G. and QWARNSTROM W. E. (1992): The role of proteoglycans in cell adhesion migration and proliferation. Curr. Opin. Cell Biol., 4, 793-801.
112. YAMADA K. M. (1991): Adhesive recognition sequences. J. Biol. Chem., 266, 12809-12812.
113. YEUNG A., ANDERSON T., MEREDITH I., UEHATA A., RYAN T., SELWYN A., MUDGE G. and GANZ P. (1992): Endothelial dysfunction in the development and detection of transplant coronary artery disease. J. Heart Lung Transplant., 11, 69-73.
114. ZHU L., HINEK A., WINGLE D., KOBAYASHI J., ZUKER M., DODO H., KEELEY F. W. and RABINOVITCH M. (1994): Endogenous vascular elastase which governs the development and progression of monocroataline-induced pulmonary hypertension is related to serine proteinase. J. Clin. Invest., 94, 1163-1171.